About UsSee Our Gifts
Memorial Sloan-Kettering Cancer Center (MSKCC) is the world’s oldest and largest private institution dedicated to prevention, patient care, research, and education in cancer. From its earliest days, MSKCC has devoted unparalleled energy and resources to the effort to control cancer in all its forms. One of MSKCC’s great strengths is the seamless integration of basic and clinical research, which ensures that discoveries in the laboratory are rapidly transferred to patients.
To offer the best possible treatments for patients with cancer today; to conduct research to discover more effective strategies to diagnose and treat cancer tomorrow; and to train future generations.
Memorial Sloan-Kettering Cancer Center consists of Memorial Hospital, the Sloan-Kettering Institute (SKI), and the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan-Kettering. Memorial Hospital, a 425-bed facility, is devoted to cancer care, clinical research, and physician training in oncology. The hallmark of care at Memorial Sloan-Kettering is to provide the most sophisticated treatment and best possible quality of life for patients with cancer and allied diseases. Our physicians emphasize early detection, more precise diagnosis, individually tailored treatment, and concern for the patient as a whole. The Sloan-Kettering Institute is dedicated to advancing the understanding of the biology and management of cancer. SKI carries out ground-breaking laboratory research through eight innovative research programs in Cancer Biology and Genetics, Cell Biology, Computational Biology, Developmental Biology, Immunology, Molecular Biology, Molecular Pharmacology and Chemistry, and Structural Biology which are home to a total of 90 laboratories. The Gerstner Sloan-Kettering Graduate School was established to narrow the gap between basic cancer research and clinical applications by training a cadre of gifted young scientists to attack clinical problems through basic and translational research. It offers a PhD program in cancer biology.
Memorial Sloan-Kettering Cancer Center has devoted more than a century to integrating patient care with an active, vital program of research, resulting in seminal contributions to new and better therapies for the treatment of cancer. We are proud of the progress we have made in the fight against cancer, as well of our extraordinary institution and our staff of more than 9,000 employees. Their dedication, teamwork, and talent make a difference in the lives of our patients today and those we will see in the future.
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 1006551
A Gift Card
Discover New Drugs
Your gift will enable Memorial Sloan-Kettering Cancer Center to continue to be on the forefront of research into new colorectal chemotherapy drugs. Memorial Sloan-Kettering helped establish the efficacy of irinotecan, the first new drug for colorectal cancer in 40 years. In some patients, irinotecan has been found to shrink metastatic tumors when other treatments have failed.
Treat and Prevent
Lung cancer research
Your gift will support current research into new agents to treat lung cancer and prevent its recurrence. Memorial Sloan-Kettering researchers are evaluating new drugs for lung cancer, including getifinib (Iressa). First tested at MSKCC, getitinib is one of a new class of drugs known as signal transduction inhibitors, which work by blocking the signal that make cancer cells grow and spread.
Breast cancer research
Your gift will support the research of our physicians and scientists who continue to pioneer new medical treatments in breast cancer research such as immunotherapy, including vaccines and antibodies. Memorial Sloan-Kettering’s vaccine studies are designed to identify the best way to harness the body’s immune system to ward off recurrences. Our doctors have tested several monoclonal antibodies. They have so far demonstrated that this approach...
Living beyond cancer
Today 10 million people in the U.S. are cancer survivors. In response to the increasing number of patients who are living beyond cancer, Memorial Sloan-Kettering Cancer Center has established the Cancer Survivorship Initiative to institute a comprehensive program of services for cancer survivors and their families and to develop a survivorship research effort that will address issues vital to survivors nationwide.
The Integrative Medicine Service at Memorial Sloan-Kettering Cancer Center was established in 1999 to complement mainstream medical care and address the emotional, social, and spiritual needs of patients and families. The Service includes inpatient and outpatient clinical care, research, and education and training. In addition, the Service provides unique access to otherwise unavailable information about over-the-counter products and unproven cancer treatments and their impact in...
Memorial Sloan-Kettering Cancer Center is one of only a few centers that offer computer-assisted family history analysis. Men with a family history of prostate cancer that suggests they may be at increased genetic risk for developing the disease can be referred to our genetic counselors who will help further evaluate their risks. Your gift will ensure that our researchers and physicians continue to make new...
Free patient care
Memorial Sloan-Kettering Cancer Center has a longstanding commitment to providing the best cancer care to everyone regardless of their ability to pay. Your gift will ensure MSKCC continues to make this vital assistance available to as many of our patients and their families as possible so that they may focus on their most important role—successfully undergoing cancer treatment.
Treat Young Patients
Memorial Sloan-Kettering Cancer Center offers care that is unequaled in depth of experience and expertise in the treatment of cancer affecting children, teenagers, and young adults. The multidisciplinary approach at Memorial Sloan-Kettering offers children and young adults with cancer the best opportunity for accurate diagnosis and the most effective treatment available, emphasizing treatments that target and cure cancer and return children to a normal life....